Letter, 2024

CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomes

CARDIOVASCULAR DIABETOLOGY, ISSN 1475-2840, Volume 23, 1, 10.1186/s12933-024-02180-8

Contributors

Schnell, Oliver (Corresponding author) [1] [2] Barnard-Kelly, Katharine [3] Battelino, Tadej [4] [5] Ceriello, Antonio [6] Larsson, Helena Elding [7] [8] Fernandez-Fernandez, Beatriz [9] Forst, Thomas [10] Frias, Juan-Pablo [11] Gavin, James R. [12] Giorgino, Francesco [13] Groop, Per-Henrik [14] [15] [16] Heerspink, Hiddo J. L. [17] Herzig, Stephan [1] [2] Hummel, Michael [1] [2] Huntley, George [18] Ibrahim, Mahmoud [19] Itzhak, Baruch [20] [21] [22] Jacob, Stephan [23] Ji, Linong [24] Kosiborod, Mikhail [25] [26] [27] Lalic, Nebosja [28] [29] Macieira, Sofia [30] Malik, Rayaz A. [31] [32] Mankovsky, Boris [33] Marx, Nikolaus [34] [35] Mathieu, Chantal [36] Mueller, Timo D. [37] [38] Ray, Kausik [39] Rodbard, Helena W. [40] Rossing, Peter [41] [42] Ryden, Lars [43] Schumm-Draeger, Petra-Maria [44] Schwarz, Peter [45] [46] Skrha, Jan [47] Snoek, Frank [48] Tacke, Frank [49] [50] [51] Taylor, Bruce [52] Jeppesen, Britta Tendal [53] Tesfaye, Solomon [54] Topsever, Pinar [55] Vilsboll, Tina [41] [42] Yu, Xuefeng [56] Standl, Eberhard [1] [2]

Affiliations

  1. [1] Helmholtz Ctr Munich, Forschergruppe Diabet eV, Ingolstaedter Landstr 1, D-85764 Neuherberg, Munich, Germany
    2. [NORA names: Germany; Europe, EU; OECD];
  2. [2] Helmholtz Ctr Munich, Forschergruppe Diabet eV, Ingolstaedter Landstr 1, D-85764 Neuherberg, Munich, Germany
    3. [NORA names: Germany; Europe, EU; OECD];
  3. [3] Southern Hlth NHS Fdn Trust, Southampton, England
    4. [NORA names: United Kingdom; Europe, Non-EU; OECD];
  4. [4] Univ Med Ctr Ljubljana, Ljubljana, Slovenia
    5. [NORA names: Slovenia; Europe, EU; OECD];
  5. [5] Univ Ljubljana, Fac Med, Ljubljana, Slovenia
    6. [NORA names: Slovenia; Europe, EU; OECD];

Abstract

Abstract not displayed. As this article is not marked as Open Access, it is unclear if we are allowed to show the abstract. Please use the link in the sidebar to view the data provider version of the article including abstract.

Keywords

CGM, Cardiovascular disease, Chronic kidney disease, Diabetes, Finerenone, GLP-1 RA, Guidelines, Heart failure, MASLD, NAFLD, Obesity, SGLT2 inhibitor, Teplizumab

Data Provider: Clarivate

LINKS
-

Matching Records in NORA

SUBJECTS
+

METRICS
+